<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Terada Y</submitter><funding>BLRD VA</funding><funding>NIBIB NIH HHS</funding><funding>NIAID NIH HHS</funding><funding>NHLBI NIH HHS</funding><funding>NIAMS NIH HHS</funding><pagination>115380</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12756909</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>44(3)</volume><pubmed_abstract>Triggering receptor expressed on myeloid cells 1 (TREM-1) has been shown to amplify inflammatory signals, such as Toll-like receptor signaling, after infection and sterile injury. While previous studies have demonstrated that TREM-1 activation in circulating immune cells promotes injury, the role of TREM-1 signaling in tissue-resident cells in the context of sterile inflammation remains poorly understood. Here, we used a cardiac transplantation model to dissect how Trem1/3 expression on heart-resident cells regulates sterile inflammation. TREM-1 is expressed in heart-resident C-C chemokine receptor 2 (CCR2)&lt;sup>+&lt;/sup> macrophages in mice and humans. TREM-1/3 signaling in tissue-resident CCR2&lt;sup>+&lt;/sup> macrophages promotes C-C motif chemokine ligand 3 (CCL3) production and is critical fo</pubmed_abstract><journal>Cell reports</journal><pubmed_title>Tissue-resident CCR2&amp;lt;sup&amp;gt;+&amp;lt;/sup&amp;gt; macrophage TREM-1/3 signaling is necessary for monocyte and neutrophil recruitment to injured hearts.</pubmed_title><pmcid>PMC12756909</pmcid><funding_grant_id>I01 BX002730</funding_grant_id><funding_grant_id>P30 AR073752</funding_grant_id><funding_grant_id>R35 HL161185</funding_grant_id><funding_grant_id>R01 HL151078</funding_grant_id><funding_grant_id>P01 AI116501</funding_grant_id><funding_grant_id>R01 HL094601</funding_grant_id><funding_grant_id>P41 EB025815</funding_grant_id><funding_grant_id>R35 HL145212</funding_grant_id><pubmed_authors>Nava RG</pubmed_authors><pubmed_authors>Gelman AE</pubmed_authors><pubmed_authors>Heo GS</pubmed_authors><pubmed_authors>Colonna M</pubmed_authors><pubmed_authors>Wein AN</pubmed_authors><pubmed_authors>Lavine KJ</pubmed_authors><pubmed_authors>Kreisel D</pubmed_authors><pubmed_authors>Bery AI</pubmed_authors><pubmed_authors>Prabhu SD</pubmed_authors><pubmed_authors>Terada Y</pubmed_authors><pubmed_authors>Li W</pubmed_authors><pubmed_authors>Dun H</pubmed_authors><pubmed_authors>Koenig AL</pubmed_authors><pubmed_authors>Liu Y</pubmed_authors><pubmed_authors>Cella M</pubmed_authors><pubmed_authors>Luehmann HP</pubmed_authors><pubmed_authors>Ritter JH</pubmed_authors><pubmed_authors>Liu CR</pubmed_authors><pubmed_authors>Owen MC</pubmed_authors><pubmed_authors>Frye CC</pubmed_authors><pubmed_authors>Amrute JM</pubmed_authors><pubmed_authors>Nunna V</pubmed_authors></additional><is_claimable>false</is_claimable><name>Tissue-resident CCR2&amp;lt;sup&amp;gt;+&amp;lt;/sup&amp;gt; macrophage TREM-1/3 signaling is necessary for monocyte and neutrophil recruitment to injured hearts.</name><description>Triggering receptor expressed on myeloid cells 1 (TREM-1) has been shown to amplify inflammatory signals, such as Toll-like receptor signaling, after infection and sterile injury. While previous studies have demonstrated that TREM-1 activation in circulating immune cells promotes injury, the role of TREM-1 signaling in tissue-resident cells in the context of sterile inflammation remains poorly understood. Here, we used a cardiac transplantation model to dissect how Trem1/3 expression on heart-resident cells regulates sterile inflammation. TREM-1 is expressed in heart-resident C-C chemokine receptor 2 (CCR2)&lt;sup>+&lt;/sup> macrophages in mice and humans. TREM-1/3 signaling in tissue-resident CCR2&lt;sup>+&lt;/sup> macrophages promotes C-C motif chemokine ligand 3 (CCL3) production and is critical fo</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Mar</publication><modification>2026-06-09T05:17:14.318Z</modification><creation>2026-06-09T03:07:44.353Z</creation></dates><accession>S-EPMC12756909</accession><cross_references><pubmed>40042972</pubmed><doi>10.1016/j.celrep.2025.115380</doi></cross_references></HashMap>